MASI's strong Q3 2025 results, FDA clearance and partnerships fuel growth hopes, but SET dependence and reimbursement risks ...

Masimo (NASDAQ: MASI) today announced that its management will participate in the J.P. Morgan 2026 Healthcare Conference on Wednesday, January 14, 2026 at 2:15 p.m. Pacific time. A live webcast of the ...

Masimo Corporation (NASDAQ:MASI) is one of the best NASDAQ stocks to buy in 2026. On December 5, Wells Fargo raised the ...

Mixed bag of news for Apple as Masimo tumbles in quality despite patent win, on-device AI threatens data centers, and the Tim ...

Apple was at risk of having imports of all Apple Watches halted because of an ongoing legal dispute. Here’s what happened.

Masimo CEO Joe Kiani, whose medical-technology company is in the midst of a proxy battle with activist Politan, revealed what he called confidential information to a major investor 12 hours before it ...

Despite a $634M patent win over Apple, Masimo's Quality score sinks to 10.43. See why fundamentals are lagging in our latest analysis.

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks ...

Medical device company Masimo has accused Apple of patent infringement, filing a complaint against the company with the U.S. International Trade Commission yesterday. Bloomberg, which first spotted ...

Masimo CEO Joe Kiani does not believe that Apple will be able to solve its patent infringement issues with software, reports Bloomberg. In an interview with Bloomberg TV, Kiani said that a software ...

Apple on Thursday began selling revised models of the Apple Watch Series 9 and Ultra 2 in the US without the blood oxygen feature as the company faces a patent dispute with medical company Masimo. In ...

Masimo reported positive Q4 results. However, investors weren't happy with the company's plan to acquire Sound United. The concerns center on whether Sound United, a consumer tech company, is a good ...